# Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma

> **NCT02615106** · PHASE2 · UNKNOWN · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 60 (estimated)

## Conditions studied

- Neuroblastoma

## Interventions

- **DRUG:** Endostar
- **RADIATION:** 21.6Gy/12Fx to the tumor bed and 36Gy/20Fx to the tumor

## Key facts

- **NCT ID:** NCT02615106
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2017-11
- **Final completion:** 2018-11
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2016-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02615106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02615106, "Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02615106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*